Smith & Nephew PLC
LSE:SN
P/OCF
Price to OCF
Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.
Market Cap | P/OCF | ||||
---|---|---|---|---|---|
UK |
Smith & Nephew PLC
LSE:SN
|
8.9B GBP | 18.6 | ||
US |
Abbott Laboratories
NYSE:ABT
|
181.1B USD | 25.4 | ||
US |
Intuitive Surgical Inc
NASDAQ:ISRG
|
141.5B USD | 82.8 | ||
US |
Stryker Corp
NYSE:SYK
|
127.5B USD | 36.7 | ||
IE |
Medtronic PLC
NYSE:MDT
|
114.2B USD | 17.7 | ||
US |
Boston Scientific Corp
NYSE:BSX
|
109.7B USD | 44.3 | ||
US |
Becton Dickinson and Co
NYSE:BDX
|
68.6B USD | 18.2 | ||
DE |
Siemens Healthineers AG
XETRA:SHL
|
59.2B EUR | 30.6 | ||
US |
Edwards Lifesciences Corp
NYSE:EW
|
53.7B USD | 59.9 | ||
US |
Dexcom Inc
NASDAQ:DXCM
|
52B USD | 64.9 | ||
CN |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
373.7B CNY | 29.7 |
P/OCF Forward Multiples
Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.